【2h】

Huntington Disease (Chorea) in the Middle East

机译:中东亨廷顿病(Chorea)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Huntington disease (HD) has been reported in Arab families in several Middle East countries including Saudi Arabia, Oman, Syria, Lebanon, and Egypt and in non-Arab populations in other countries in the region. It is probably under-reported, and until now, has not been recorded in Yemen, the United Arab Emirates, Jordan or in Iraq. The Middle East has always been on the crossroads of trade and travel, and HD was probably introduced to some of these countries in previous times. The prevalence rate in Middle Eastern Arabs is estimated to vary from 3 to 4 per 100,000. Although the HD gene which codes for the protein huntingtin has been identified, the function of this protein is not known. At present, no treatment has been found to delay the onset of HD or to treat it effectively. Although relatively rare, HD has increasingly become a focus of international gene research, with the support and collaboration of the International Huntington Association (IHA). The IHA has been represented in Saudi Arabia and Oman.
机译:在包括沙特阿拉伯,阿曼,叙利亚,黎巴嫩和埃及在内的几个中东国家的阿拉伯家庭以及该地区其他国家的非阿拉伯人口中都报告了亨廷顿病(HD)。该报告可能未得到充分报道,到目前为止,也门,阿拉伯联合酋长国,约旦或伊拉克尚未有记录。中东一直处在贸易和旅行的十字路口,高清可能是在以前的某些国家引入的。中东阿拉伯人的患病率估计为每100,000人3至4人。尽管已鉴定出编码亨廷顿蛋白的HD基因,但该蛋白的功能尚不清楚。目前,还没有发现可以延缓HD发作或有效治疗的方法。尽管相对罕见,但在国际亨廷顿协会(IHA)的支持和合作下,高清已日益成为国际基因研究的重点。 IHA在沙特阿拉伯和阿曼都有代表。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号